These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7040887)
1. A new test of peripheral insulin sensitivity in vivo using artificial beta cell. Valenta LJ; Elias AN; Grossman M; Tanner SM; Friis R Life Sci; 1982 Mar; 30(10):867-73. PubMed ID: 7040887 [TBL] [Abstract][Full Text] [Related]
2. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance. Ratzmann KP; Schneider U; Peters U; Ziegler M; Schulz B Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073 [TBL] [Abstract][Full Text] [Related]
3. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp. Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652 [TBL] [Abstract][Full Text] [Related]
4. Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance. Schulz B; Ratzmann KP; Albrecht G; Bibergeil H Exp Clin Endocrinol; 1983 May; 81(3):263-72. PubMed ID: 6350027 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping. Ponchner M; Heine RJ; Pernet A; Hanning I; Francis AJ; Cook D; Orskov H; Alberti KG Diabetologia; 1984 Jun; 26(6):420-5. PubMed ID: 6381189 [TBL] [Abstract][Full Text] [Related]
6. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique. Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA). Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967 [TBL] [Abstract][Full Text] [Related]
8. Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: effect of chromium supplementation in diabetic patients. Elias AN; Grossman MK; Valenta LJ Gen Pharmacol; 1984; 15(6):535-9. PubMed ID: 6526265 [TBL] [Abstract][Full Text] [Related]
9. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845 [TBL] [Abstract][Full Text] [Related]
10. [Use of an artificial B-cell in clinic and experimental medicine]. Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292 [TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Frias JP; Yu JG; Kruszynska YT; Olefsky JM Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970 [TBL] [Abstract][Full Text] [Related]
12. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects. Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720 [TBL] [Abstract][Full Text] [Related]
13. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM). Ratzmann KP; Schneider U; Besch W; Heinke P Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851 [TBL] [Abstract][Full Text] [Related]
14. [Normoglycemic control by artificial pancreas in patients with pancreatic diabetes or with primary diabetes mellitus--analysis of patterns of insulin infusion and nocturnal glucose infusion]. Yoshida Y; Koizumi M; Abe N; Ishizuka J; Sanoyama K; Goto Y Nihon Shokakibyo Gakkai Zasshi; 1989 Mar; 86(3):786-92. PubMed ID: 2770020 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics. Wajngot A; Roovete A; Vranić M; Luft R; Efendić S Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603 [TBL] [Abstract][Full Text] [Related]
17. Use of an artificial beta cell in surgery. Horwitz DL; Schwartz SS Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072 [TBL] [Abstract][Full Text] [Related]
18. Use of the artificial B-cell (Biostator) in improving insulin therapy in unstable insulin-dependent diabetes. Ratzmann KP; Bruns W; Schulz B; Zander E Diabetes Care; 1982; 5(1):11-7. PubMed ID: 6754298 [TBL] [Abstract][Full Text] [Related]
19. The euglycemic clamp technique in patients with liver cirrhosis. Vannini P; Forlani G; Marchesini G; Ciavarella A; Zoli M; Pisi E Horm Metab Res; 1984 Jul; 16(7):341-3. PubMed ID: 6386642 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Catalano PM; Huston L; Amini SB; Kalhan SC Am J Obstet Gynecol; 1999 Apr; 180(4):903-16. PubMed ID: 10203659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]